Local administration with silymarin could increase osseointegration of hydroxyapatite-coated titanium implants in ovariectomized rats
- 25 July 2019
- journal article
- research article
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 34 (5) , 664-672
Abstract
As hydroxyapatite has good osteoconductive properties, it is used as coating material for the implants in cementless arthroplasty. However, its effect is not sufficient for osteoporotic bone. Silymarin promotes osteoblast proliferation and inhibits osteoclast proliferation, and positively affects bone regeneration. System administration of silymarin increases bone strength and both cancellous and cortical bone mass. The aim of this study was to confirm the effect of the local incorporation silymarin into hydroxyapatite-coated titanium implants in the osteoporotic and normal condition. Twelve-week-old female Sprague-Dawley rats were used for this study. Twelve weeks after bilateral ovariectomy, all animals were randomly divided into three groups: group sham, group ovariectomized and group silymarin, and the rats from ovariectomized and sham received hydroxyapatite implants and animals belong to group silymarin received silymarin-hydroxyapatite implants until death at 12 weeks, respectively. The bilateral femurs of rats were harvested for evaluation. All treatments increased new bone formation around the surface of titanium rods and push-out force other than group ovariectomized. Compared with group ovariectomized, group silymarin showed the strongest effects on new bone formation, biomechanical strength and regulation of osteogenesis and bone resorption-related gene expression, respectively. Additionally, these are significant difference in bone formation, gene expression and push-out force was observed among treatment groups. This finding suggests that local incorporation of silymarin is useful to improve the fixation of hydroxyapatite-coated implants in ovariectomized rats.Keywords
Funding Information
- University Natural Science Research Project of Anhui Province (KJ2017A266)
- Funding of "Peak" Training Program for Scientific Research of Yijishan Hospital, Wannan Medical College (GF2019G04, GF2019T02, PF2019005, PF2019007)
This publication has 43 references indexed in Scilit:
- The Free Fatty Acid Receptor G Protein-coupled Receptor 40 (GPR40) Protects from Bone Loss through Inhibition of Osteoclast Differentiation*Journal of Biological Chemistry, 2013
- Preparation and evaluation of parathyroid hormone incorporated CaP coating via a biomimetic methodJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2011
- The effect of strontium-substituted hydroxyapatite coating on implant fixation in ovariectomized ratsBiomaterials, 2010
- Silibinin Inhibits Osteoclast Differentiation Mediated by TNF Family MembersMolecules and Cells, 2009
- NF‐κB in liver diseases: a target for drug therapyJournal of Applied Toxicology, 2008
- European guidance for the diagnosis and management of osteoporosis in postmenopausal womenOsteoporosis International, 2008
- Trabecular Bone Gradient in Rat Long Bone Metaphyses: Mathematical Modeling and Application to Morphometric Measurements and Correction of Implant PositioningJournal of Bone and Mineral Research, 2008
- The significance of infection related to orthopedic devices and issues of antibiotic resistanceBiomaterials, 2006
- Bone Morphogenetic ProteinsGrowth Factors, 2004
- Osteoporosis Prevention, Diagnosis, and TherapyJAMA, 2001